Fonte: Haematologica. Nome do evento: Congress of The European Hematology Association. Unidades: FMRP, FCFRP
Assuntos: EXPRESSÃO GÊNICA, APOPTOSE, ONCOGENES, LEUCEMIA MIELÓIDE
ABNT
FERREIRA, A. et al. Tyrosine kinase inhibitors modulate the apoptomirs: MIR-16, MIR-21, MIR-30E, MIR-145, MIR-142-3P, MIR-LET-7D, MIR-LET-7E and MIR-15A expression in BCR-ABL-positive cell. Haematologica. Pavia: Faculdade de Medicina de Ribeirão Preto, Universidade de São Paulo. . Acesso em: 10 out. 2024. , 2011APA
Ferreira, A., Moura, L., Simoes, B. P., Silva Júnior, W. A. da, Kashima, S., Covas, D. T., et al. (2011). Tyrosine kinase inhibitors modulate the apoptomirs: MIR-16, MIR-21, MIR-30E, MIR-145, MIR-142-3P, MIR-LET-7D, MIR-LET-7E and MIR-15A expression in BCR-ABL-positive cell. Haematologica. Pavia: Faculdade de Medicina de Ribeirão Preto, Universidade de São Paulo.NLM
Ferreira A, Moura L, Simoes BP, Silva Júnior WA da, Kashima S, Covas DT, Souza AM de, Castro FA de. Tyrosine kinase inhibitors modulate the apoptomirs: MIR-16, MIR-21, MIR-30E, MIR-145, MIR-142-3P, MIR-LET-7D, MIR-LET-7E and MIR-15A expression in BCR-ABL-positive cell. Haematologica. 2011 ; 96 597-598.[citado 2024 out. 10 ]Vancouver
Ferreira A, Moura L, Simoes BP, Silva Júnior WA da, Kashima S, Covas DT, Souza AM de, Castro FA de. Tyrosine kinase inhibitors modulate the apoptomirs: MIR-16, MIR-21, MIR-30E, MIR-145, MIR-142-3P, MIR-LET-7D, MIR-LET-7E and MIR-15A expression in BCR-ABL-positive cell. Haematologica. 2011 ; 96 597-598.[citado 2024 out. 10 ]